Title: Chief Scientific Advisor
Company: BBSG Pharma Associates
Location: Corona, California, United States
Gur Singh, Chief Scientific Advisor at BBSG Pharma Associates, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in toxicology.
Dr. Singh’s illustrious career in the field of toxicology spans over three decades and continents, marked by his unwavering dedication to scientific advancement and regulatory excellence. Armed with a Ph.D. in toxicology from the University of Birmingham, England, attained in 1981, and prior academic achievements from Punjab Agricultural University in India, his educational foundation laid the groundwork for his impactful career.
Throughout his professional journey, Dr. Singh held pivotal roles in both the public and private sectors. Notably, from 1991 to 2006, he served as a reviewer, senior expert, and team leader at the U.S. Food and Drug Administration (FDA), where he played a vital role in streamlining drug approval processes and facilitating generic medicine approvals. In 2006, he transitioned to Watson Laboratories as the director of inhalation drug product strategy and biopharmaceutics, where he contributed until 2009.
From 2009 to 2012, Dr. Singh served as the head of clinical and regulatory affairs at Axar Pharmaceuticals. In 2013, he assumed the position of senior vice president and head of the respiratory center of excellence at Cipla, where he remained until 2023. His pivotal role at Cipla underscored his commitment to enhancing regulatory rationalization for respiratory drug product development, ensuring broader access to affordable medications for patients worldwide. In 2023, Dr. Singh founded BBSG Pharma Associates, a California-based consultancy, where he currently serves as the chief scientific advisor, spearheading a diverse, cross-functional team in respiratory product development.
Driven by a relentless pursuit of excellence, Dr. Singh remains committed to staying at the forefront of advancements in his field. His affiliation with esteemed international societies and organizations, such as the International Society for Aerosols in Medicine and the American College of Pharmacology, underscores his commitment to collaboration and knowledge sharing on a global scale.
While Dr. Singh’s career has been marked by numerous accolades and achievements, he takes the utmost pride in his contributions to enhancing rationalized respiratory drug product development. His efforts in developing regulatory paradigms to reduce the cost of drug development reflect his dedication to advancing the pharmaceutical industry for the greater good.
Dr. Singh attributes his success to the unwavering support and love of his parents, as well as the opportunities for professional growth and outstanding peer interactions that have shaped his career trajectory. Looking ahead, he remains focused on the development of inhaled biologics and aims to tackle the multifaceted challenges present in respiratory drug development with innovation and determination.
For more information, please visit:
Contact Dr. Singh:
